Cargando…
Epithelial-mesenchymal transition markers screened in a cell-based model and validated in lung adenocarcinoma
BACKGROUND: Re-capture of the differences between tumor and normal tissues observed at the patient level in cell cultures and animal models is critical for applications of these cancer-related differences. The epithelial-mesenchymal transition (EMT) process is essential for tumor migratory and invas...
Autores principales: | Song, Jing, Wang, Wenqing, Wang, Yingyan, Qin, Yongxin, Wang, Yingzi, Zhou, Jian, Wang, Xuelian, Zhang, Yi, Wang, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624955/ https://www.ncbi.nlm.nih.gov/pubmed/31296175 http://dx.doi.org/10.1186/s12885-019-5885-9 |
Ejemplares similares
-
The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis
por: Wang, Changli, et al.
Publicado: (2012) -
Systematic construction and validation of an epithelial–mesenchymal transition risk model to predict prognosis of lung adenocarcinoma
por: Tang, Yunliang, et al.
Publicado: (2020) -
Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas
por: Li, Hui, et al.
Publicado: (2016) -
Cancer-associated fibroblast-derived SDF-1 induces epithelial-mesenchymal transition of lung adenocarcinoma via CXCR4/β-catenin/PPARδ signalling
por: Wang, Yingyan, et al.
Publicado: (2021) -
DCBLD2 Mediates Epithelial-Mesenchymal Transition-Induced Metastasis by Cisplatin in Lung Adenocarcinoma
por: Chen, Xiaosu, et al.
Publicado: (2021)